BCTX NASDAQ
BriaCell Therapeutics Corp.
1W: -6.5%
1M: +13.2%
3M: +15.4%
YTD: -43.6%
1Y: -67.9%
3Y: -99.6%
5Y: -99.1%
$4.04
-0.07 (-1.70%)
Weekly Expected Move ±10.9%
$3
$4
$4
$4
$5
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$39M
-18.5% ▼
Capital Expenditures
$3
+100.0% ▲
Free Cash Flow
-$39M
-16.3% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$13M
+146.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$18M | -$34M | -$27M | -$7M | -$36M |
| Depreciation & Amort. | $19K | $19K | $21K | $115K | $148K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$3M | -$498K | -$5M | $10M | -$3M |
| Other Non-Cash Items | $11M | $19M | $100K | -$36M | -$80K |
| Operating Cash Flow | -$10M | -$16M | -$32M | -$33M | -$39M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | -$624K | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | -$307K | -$11M |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | -$932K | -$11M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$422K | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | -$13M | -$64K | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | -$30K | $0 | $0 | $0 |
| Financing Cash Flow | $83M | -$5M | $5M | $6M | $63M |
| Net Change in Cash | $72M | -$21M | -$26M | -$28M | $13M |
| Cash End of Period | $72M | $53M | $28M | $1M | $14M |
| Free Cash Flow | -$10M | -$16M | -$32M | -$34M | -$39M |